Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Your northwest pollen count for Tuesday, Wednesday & Thursday
Mainly dry until later on Wednesday - when the weather gets more interesting but more unsettled
The Three Queens were in Liverpool for a very special anniversary - the 175th birthday of the shipping line Cunard.